login
Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
Mad Cow Disease Kills Two in Spain
April 08, 2008 at 11:28 AM
Tropical Disease News
The two victims apparently contracted the brain-wasting disease before Spain and the European Union tightened controls on meat production in the mid-1990s following the appearance of the illness, the ministry said in a statement.
"These cases have no epidemiological consequences, that is to say, they do not put citizens' health at risk," the statement said.
Spain recorded its first and, until now, only human death from brain-wasting Creutzfeldt-Jakob disease in June 2005 when a 26-year-old woman succumbed in Madrid.
More than 200 people around the world are suspected to have died, most of them in Britain, from the human variant of the disease, which was first described in 1996.
Scientists believe the disease was caused by using infected parts of cattle to make feed for other cattle.
Authorities believe eating meat from infected animals can cause the human variant of the fatal brain-wasting disease.
The 27-member EU, of which Spain is part, banned high-risk materials such as spinal cord from use in feed and tighter labeling was also introduced.
Agriculture Minister Elena Espinosa sought to convey a message of calm, saying that "we are not in the circumstances that we were many years ago.
"The meat was consumed years ago before any type of control was established, in Spain or in the European Union," she told Cadena Ser radio.
|
|
|
 Comment & Contribute
|
Medwonders Health Network
- Health News Index
|
|
- News Quick Links
| News Categories: |
| » | Prednisolone Benefits Patients With Bell's Palsy |
| » | 'Orphan' Sleep Drug may Fight Cancer |
| » | New Drugs for Fox Tapeworm Infection |
| » | Poor Quality Antimalarial Drugs Pose Threat |
| » | New Drug Shows Promise Against Localized High-risk Prostate Tumors |
| More Drug News | |
|
